DENYES NANCY 4
4 · aTYR PHARMA INC · Filed May 26, 2022
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
DENYES NANCY
General Counsel
Transactions
- Award
Employee Stock Option (right to buy)
2022-05-24+88,097→ 88,097 totalExercise: $2.81Exp: 2032-05-24→ Common Stock (88,097 underlying)
Holdings
- 3,447
Common Stock
Footnotes (2)
- [F1]Includes 178 shares each acquired under the Company's 2015 Employee Stock Purchase Plan (ESPP) on November 15, 2021 and May 13, 2022, respectively.
- [F2]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 24, 2022, such that this option will be fully exercisable on May 24, 2026. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.